Breaking News Instant updates and real-time market news.

ILMN

Illumina

$141.54

0.05 (0.04%)

, FCX

Freeport McMoRan

$15.43

0.75 (5.11%)

09:56
01/10/17
01/10
09:56
01/10/17
09:56

Early notable gainers among liquid option names on January 10th

Notable gainers among liquid option names this morning include Illumina (ILMN) $162.43 +20.91, Freeport McMoRan (FCX) $15.39 +0.70, Zimmer Biomet (ZBH) $111.95 +4.96, Alcoa (AA) $30.76 +1.28, and Chipotle (CMG) $411.64 +16.37.

ILMN

Illumina

$141.54

0.05 (0.04%)

FCX

Freeport McMoRan

$15.43

0.75 (5.11%)

ZBH

Zimmer Biomet

$113.17

6.165 (5.76%)

AA

Alcoa

$30.25

0.77 (2.61%)

CMG

Chipotle

$409.68

14.62 (3.70%)

  • 10

    Jan

  • 10

    Jan

  • 24

    Jan

  • 02

    Feb

ILMN Illumina
$141.54

0.05 (0.04%)

01/10/17
LEER
01/10/17
NO CHANGE
Target $132
LEER
Market Perform
Illumina price target raised to $132 from $114 at Leerink
Leerink analyst Puneet Souda raised his price target for Illumina to $132 from $114 after the company announced Q4 sales, 2017 revenue and EPS guidance, and announced the launch of NovaSeq high-throughput sequencing platform. The analyst says that while he sees this instrument upgrade as "meaningful," Souda believes it will only deliver additional capacity into a market already experiencing overcapacity in the near-term. He reiterates a Market Perform on the shares.
01/10/17
PIPR
01/10/17
NO CHANGE
Target $170
PIPR
Overweight
Illumina price target raised to $170 from $148 at Piper Jaffray
Piper Jaffray analyst William Quirk raised his price target for Illumina to $170 saying the company's new high-throughput platform, NovaSeq, could "spawn a multi-year upgrade cycle." The shares typically perform well during upgrade cycles, Quirk tells investors in a research note. He keeps an Overweight rating on Illumina.
01/10/17
BOFA
01/10/17
UPGRADE
Target $175
BOFA
Buy
Illumina upgraded to Buy from Neutral at BofA/Merrill
BofA/Merrill analyst Derik de Bruin upgraded Illumina to Buy and raised its price target to $175 from $145 following the announcement of a new sequencing platform, the NovaSeq. The analyst believes the NovaSeq is a substantial improvement over the current high-end sequencing platform, the HiSeq family, and will be a major new product cycle driving top-line acceleration and approximately 20% earnings growth in 2018.
01/06/17
KING
01/06/17
UPGRADE
KING
Buy
Illumina upgraded to Buy from Neutral at CL King
FCX Freeport McMoRan
$15.43

0.75 (5.11%)

11/17/16
DBAB
11/17/16
DOWNGRADE
Target $12.5
DBAB
Hold
Freeport McMoRan downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Chris Terry downgraded Freeport McMoRan to Hold citing valuation following the recent rally in the shares. The analyst keeps a $12.50 price target for the stock.
11/21/16
COWN
11/21/16
NO CHANGE
Target $20
COWN
Outperform
Freeport McMoRan price target raised to $20 from $15 at Cowen
Cowen analyst Anthony Rizzuto raised his price target on Freeport McMoRan to $20 from $15 as the company has regained its status as the "go-to" coper investment vehicle after the impressive action taken by management to right-size the balance sheet. Rizzuto reiterated his Outperform rating on Freeport McMoRan shares.
11/30/16
BREN
11/30/16
DOWNGRADE
BREN
Sell
Freeport McMoRan downgraded to Sell from Hold at Berenberg
11/30/16
11/30/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Freeport McMoRan (FCX) downgraded to Sell from Hold at Berenberg. 2. Arrowhead (ARWR) was downgraded to Neutral from Overweight at Piper Jaffray, to Neutral from Buy at Chardan, to Hold from Buy at Cantor, and to Market Perform from Outperform at William Blair. 3. W.R. Grace (GRA) downgraded to Hold from Buy at Jefferies with analyst Laurence Alexander noting the potential for a sharp drop in free cash flow conversion once its net operating loss carry-forwards are exploited. 4. Abaxis (ABAX) downgraded to Neutral from Buy at Northcoast. 5. Duluth Holdings (DLTH) downgraded to Neutral from Outperform at Baird with analyst Jonathan Komp citing the stock's recent rally and the possibility its valuation metrics have pushed beyond the levels he believes it can sustain. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
ZBH Zimmer Biomet
$113.17

6.165 (5.76%)

01/05/17
JPMS
01/05/17
NO CHANGE
Target $134
JPMS
Overweight
JPMorgan sees Zimmer guiding 2017 below consensus
JPMorgan analyst Michael Weinstein sees Zimmer Biomet guiding 2017 earnings per share to $8.50-$8.60, below the consensus estimate of $8.68. The recent strengthening of the U.S. dollar is eating into the company's ability to deliver on its 10% EPS growth goal, Weinstein tells investors in a research note. While 2016 did not go the way Zimmer wanted, expectations are a lot lower today, the analyst contends. He sees management commentary at his firm's upcoming healthcare conference and the Q4 earnings call as potential catalysts. Weinstein keeps an Overweight rating on Zimmer with a $134 price target. The company should benefit from corporate tax reform as its 23%-24% effective rate is at the upper end of its MedTech peers, the analyst argues.
12/15/16
12/15/16
NO CHANGE

Expert says Zimmer likely to receive warning letter, says Wells Fargo
After Zimmer Bioment disclosed that it had received a Form 483 from the FDA on November 22, Wells Fargo's FDA legal consultant says that the form is "is one of the longest and most serious" he has ever seen ,and he thinks that Zimmer will probably receive a warning letter, according to the firm. The consultant does not expect the issues raised by the letter to be completely resolved until 2018 at the earliest. He thinks that the 483 and the warning letter probably won't impact Zimmer's business in the near-term, but he says that another bad inspection for the facility "could increase the risk of an injunction at some point." Such an injunction could negatively impact the company's business, Wells quotes the consultant as saying. Wells keeps an Outperform rating on the shares.
12/15/16
UBSW
12/15/16
UPGRADE
Target $133
UBSW
Buy
Stryker upgraded to Buy from Neutral at UBS
UBS analyst Matt Miksic upgraded Stryker (SYK) to Buy from Neutral after a survey of doctors conducted in conjunction with the firm's Evidence Lab showed evidence for share gain potential in the U.S. total knee market for its MAKO robotic-arm assisted surgery. The analyst, who also downgraded Zimmer Biomet (ZBH) to Sell from Neutral this morning based on concerns over the survey findings, raised his price target on Stryker shares to $133 from $121.
12/15/16
12/15/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Valeant (VRX) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst David Risinger saying the thesis that management would stabilize the business and execute asset sales has been wrong. 2. General Mills (GIS) downgraded to Sector Perform from Outperform at RBC Capital with analyst David Palmer saying he believes that accelerating U.S. volume declines which occurred over the last three months will limit the company's EPS growth. 3. Toyota (TM) downgraded to Neutral from Outperform at Macquarie. 4. Zimmer Biomet (ZBH) downgraded to Sell from Neutral at UBS with analyst Matt Miksic citing a survey of 139 U.S. orthopedic surgeons, which he said shows evidence of the share gain potential of Stryker's (SYK) MAKO in the U.S. total knee market. 5. Brinker (EAT) downgraded to Underperform from Market Perform at BMO Capital with analyst Andrew Strelzik citing valuation and the company's relatively weak margin outlook. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
AA Alcoa
$30.25

0.77 (2.61%)

12/20/16
MACQ
12/20/16
UPGRADE
Target $39
MACQ
Outperform
Alcoa upgraded due to increased aluminum forecasts at Macquarie
As previously reported, Macquarie upgraded Alcoa to Outperform from Neutral. Macquarie's Commodities increased its long-term forecast for both alumina and aluminum due to improved demand expectations and higher current spot movements. As a result, analyst Anthony Young raised is view of Alcoa and increased its price target to $39 from $30 saying it is the best way to participate in the picup in global GDP and recommends using any weakness to build or initiate positions.
12/05/16
12/05/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Alcoa (AA) downgraded to Neutral from Buy at Citi with analyst Alexander Hacking saying the risk/reward is now evenly balanced following the stock's 35% rise since November 1. 2. Marvell (MRVL) downgraded to Sell from Neutral at Goldman with analyst Mark Delaney saying the company's key markets are in secular decline while a turnaround will be more difficult following R&D spending cuts. 3. Arista Networks (ANET) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst James Faucette saying Arista's valuation reflects expected share opportunities in the data center switching market and switch-router opportunity. 4. Sotherly Hotels downgraded to Market Perform from Outperform at JMP Securities. 5. KeyCorp (KEY) downgraded to Underperform from Outperform at CLSA with analyst Mike Mayo saying Comerica (CMA) and Zions (ZION) benefit more than other large banks from higher rates, lower taxes, and exit from SIFI status, in contrast to KeyCorp which is estimated to have no benefit and has a higher valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/20/16
MACQ
12/20/16
UPGRADE
MACQ
Outperform
Alcoa upgraded to Outperform from Neutral at Macquarie
12/20/16
12/20/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly:1. NVIDIA (NVDA) upgraded to Conviction Buy from Buy at Goldman with analyst Toshiya Hari saying he expects AI/ML capacity additions to drive TAM expansion, high barriers of entry faced by competition and NVIDIA continues to leverage its position to gain greater share of the ML hardware TAM. 2. Carlyle Group (CG) upgraded to Buy from Neutral at Citi with analyst William Katz saying he expects a favorable FPAUM inflection into 2017, setting the stable for the next DE upcycle, and views valuation as compelling. 3. Alcoa (AA) upgraded to Outperform from Neutral at Macquarie saying it is the best way to participate in the pick up in global GDP and recommends using any weakness to build or initiate positions. 4. AMD (AMD) upgraded to Buy on deep learning and AI opportunity at Mizuho with analyst Vijay Rakesh saying he sees deep learning and Artificial Intelligence as the next big computing paradigm and believes the company has an opportunity for deep learning with its new Radeon ProGFx/Ryzen products. 5. Caterpillar (CAT) upgraded to Positive from Mixed at OTR Global with the firm saying its checks indicate the rate of decline in year-over-year global new equipment orders has moderated in Q4 due to strength in EMEA and Asia/Pacific. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
CMG Chipotle
$409.68

14.62 (3.70%)

01/06/17
DBAB
01/06/17
NO CHANGE
Target $280
DBAB
Sell
Deutsche stays cautious on Chipotle with $280 price target
In a research note titled "Recovery 'Is A Riddle, Wrapped Up In a Burrito, Inside A Foil,'" Deutsche Bank analyst Brett Levy keeps a Sell rating on Chipotle Mexican Grill with a $280 price target. The stock closed yesterday up $10.03 to $391.89. The investment story remains based on hope of a recovery as sales have failed to accelerate, Levy tells investors. Management is moving in the right direction but that does not mean Chipotle will reach its 2017 targets, he cautions.
01/05/17
WEDB
01/05/17
UPGRADE
WEDB
Neutral
Chipotle upgraded to Neutral from Underperform at Wedbush
01/05/17
01/05/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. MasterCard (MA) upgraded to Top Pick from Outperform at RBC Capital with analyst Daniel Perlin saying the company will benefit from improvements in the global economy, along with accelerating revenue growth, its recent acquisition of VocaLink, inflation, and new technological innovations. 2. Etsy (ETSY) upgraded to Buy from Hold at Loop Capital with analyst Blake Harper saying the company has done something most other retailers have not - fend off competition from Amazon (AMZN). The analyst does not expect Amazon to attract a meaningful share of Etsy shops and products. He raised his price target for Etsy shares to $16 from $14. 3. Chipotle (CMG) upgraded to Neutral from Underperform at Wedbush. 4. Progressive (PGR) upgraded to Equal Weight from Underweight at Morgan Stanley with analyst Kai Pan expecting core margins to inflect in 2017 due to a moderation in new business "drag," easier commercial auto comps in the second half of 2017, and sees additional upside from a lower tax rate and rising yield. 5. Southwest (LUV) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Rajeev Lalwani citing its Domestic exposure and defensive positioning. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/06/17
UBSW
01/06/17
NO CHANGE
Target $410
UBSW
Neutral
Chipotle sales recovery remains elusive, says UBS
UBS analyst Dennis Geiger noted Chipotle implemented an enhanced food safety program and robust marketing and promotions and other traffic enhancing efforts but the sales recovery remains elusive. The analyst said without a more accelerated sales recovery, margins are likely to remain depressed. Geiger maintained his Neutral rating and $410 price target on Chipotle shares.

TODAY'S FREE FLY STORIES

TECK

Teck Resources

$16.13

0.825 (5.39%)

12:30
06/22/17
06/22
12:30
06/22/17
12:30
Options
Defensive option play in Teck Resources as shares rally »

Defensive option play in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$153.91

1.66 (1.09%)

12:22
06/22/17
06/22
12:22
06/22/17
12:22
Hot Stocks
Facebook holds communities event, announces new mission »

Facebook hosted its first…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 28

    Jun

  • 19

    Jul

FLR

Fluor

$44.29

0.52 (1.19%)

12:20
06/22/17
06/22
12:20
06/22/17
12:20
Options
Flour calls seeing opening interest »

Flour calls seeing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

12:17
06/22/17
06/22
12:17
06/22/17
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

12:16
06/22/17
06/22
12:16
06/22/17
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSIQ

Canadian Solar

$13.99

0.94 (7.20%)

12:10
06/22/17
06/22
12:10
06/22/17
12:10
Options
Notable call buying in Canadian Solar as shares shine »

Notable call buying in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:10
06/22/17
06/22
12:10
06/22/17
12:10
General news
Treasury Option Action: a call 1x2 on 10s »

Treasury Option Action: a…

SRSC

Sears Canada

$0.47

-0.115 (-19.69%)

12:05
06/22/17
06/22
12:05
06/22/17
12:05
Hot Stocks
Breaking Hot Stocks news story on Sears Canada »

Sears Canada trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NLSN

Nielsen

$37.08

-0.15 (-0.40%)

, GOOG

Alphabet

$959.45

8.82 (0.93%)

12:01
06/22/17
06/22
12:01
06/22/17
12:01
Hot Stocks
Nielsen launches mobile measurement for YouTube ads »

Nielsen (NLSN) announced…

NLSN

Nielsen

$37.08

-0.15 (-0.40%)

GOOG

Alphabet

$959.45

8.82 (0.93%)

GOOGL

Alphabet Class A

$978.59

9.6 (0.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 28

    Jun

  • 19

    Jul

AKS

AK Steel

$6.25

0.055 (0.89%)

12:00
06/22/17
06/22
12:00
06/22/17
12:00
Options
AK Steel Jul 8 calls are today's most active option »

AK Steel Jul 8 calls are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

CVM

CEL-SCI

$1.75

0.0576 (3.41%)

11:58
06/22/17
06/22
11:58
06/22/17
11:58
Hot Stocks
Breaking Hot Stocks news story on CEL-SCI 

Cel Sci trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HAIN

Hain Celestial

$33.16

0.13 (0.39%)

11:55
06/22/17
06/22
11:55
06/22/17
11:55
Hot Stocks
Hain Celestial CEO says he has a strong management team backing him »

The Hain Celestial CEO is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

  • 27

    Jun

HAIN

Hain Celestial

$33.16

0.13 (0.39%)

, AMZN

Amazon.com

$1,002.23

9.64 (0.97%)

11:53
06/22/17
06/22
11:53
06/22/17
11:53
Hot Stocks
Hain Celestial says Amazon deal for Whole Foods will give more exposure »

The Hain Celestial CEO is…

HAIN

Hain Celestial

$33.16

0.13 (0.39%)

AMZN

Amazon.com

$1,002.23

9.64 (0.97%)

WFM

Whole Foods

$43.26

0.48 (1.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

  • 27

    Jun

  • 28

    Jun

SPLS

Staples

$8.66

-0.09 (-1.03%)

11:47
06/22/17
06/22
11:47
06/22/17
11:47
Recommendations
Staples analyst commentary  »

Staples intrinsic value…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MMSI

Merit Medical

$36.80

-0.2 (-0.54%)

11:46
06/22/17
06/22
11:46
06/22/17
11:46
Recommendations
Merit Medical analyst commentary  »

Merit Medical allowance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

FSLR

First Solar

$37.23

1.78 (5.02%)

11:45
06/22/17
06/22
11:45
06/22/17
11:45
Options
First Solar call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

ABBV

AbbVie

$72.80

1.455 (2.04%)

11:44
06/22/17
06/22
11:44
06/22/17
11:44
Upgrade
AbbVie rating change  »

AbbVie upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMC

Commercial Metals

$18.47

0.06 (0.33%)

11:38
06/22/17
06/22
11:38
06/22/17
11:38
Hot Stocks
Breaking Hot Stocks news story on Commercial Metals »

Commercial Metals says a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

LPNT

LifePoint

$64.85

0.25 (0.39%)

, CYH

Community Health

$9.56

0.74 (8.39%)

11:35
06/22/17
06/22
11:35
06/22/17
11:35
Hot Stocks
Hosptial stocks at highs after Republicans release ACHA 'discussion draft' »

Publicly traded companies…

LPNT

LifePoint

$64.85

0.25 (0.39%)

CYH

Community Health

$9.56

0.74 (8.39%)

THC

Tenet

$18.94

1.26 (7.13%)

HCA

HCA Holdings

$87.44

3.39 (4.03%)

UHS

Universal Health

$116.28

3.06 (2.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYL

Mylan

$38.27

0.85 (2.27%)

11:26
06/22/17
06/22
11:26
06/22/17
11:26
Periodicals
Mylan investors vote against executive pay, re-elect board members, Reuters says »

Mylan shareholders voted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

  • 13

    Jul

  • 03

    Sep

  • 09

    Oct

11:25
06/22/17
06/22
11:25
06/22/17
11:25
General news
Treasury announced an $88 B package of coupon offerings for next week »

Treasury announced an $88…

V

Visa

$94.25

-0.29 (-0.31%)

11:23
06/22/17
06/22
11:23
06/22/17
11:23
Hot Stocks
Breaking Hot Stocks news story on Visa »

Visa says 'engaged…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

KR

Kroger

$22.12

-0.2542 (-1.14%)

11:21
06/22/17
06/22
11:21
06/22/17
11:21
Hot Stocks
Kroger board approves $1B share repurchase program, raises quarterly dividend »

The Kroger Co.'s…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

V

Visa

$94.21

-0.33 (-0.35%)

11:20
06/22/17
06/22
11:20
06/22/17
11:20
Hot Stocks
Visa says continues to pursue domestic license in China »

Says regulation a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

BAC

Bank of America

$23.02

-0.115 (-0.50%)

11:20
06/22/17
06/22
11:20
06/22/17
11:20
Options
Big block of BofA calls as shares dip »

Big block of BofA calls…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.